acridine orange has been researched along with Brain Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curry, B; Rewcastle, NB; Sarnat, HB; Trevenen, CL | 1 |
| Araujo, FG; Dannemann, BR; Morris, VA; Remington, JS | 1 |
2 other study(ies) available for acridine orange and Brain Disorders
| Article | Year |
|---|---|
Gliosis and glioma distinguished by acridine orange.
Topics: Acridine Orange; Adolescent; Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Glioma; Gliosis; Humans; Infant; Infant, Newborn; Middle Aged; RNA | 1987 |
Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
Topics: Acridine Orange; Animals; Antibodies, Protozoan; Antigens, Protozoan; Brain Diseases; Chromium Radioisotopes; Complement System Proteins; Cysts; Cytotoxicity, Immunologic; Ethidium; Female; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Activation; Mice; Staining and Labeling; Toxoplasma; Toxoplasmosis, Animal | 1989 |